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ABSTRACT 
Preorganized ligands have proven to be important to inorganic chemistry, yielding higher 
stability constants and sharper metal ion selectivity than their more flexible analogs.  These 
ligands may have important applications in the biomedical, environmental, and industrial fields, 
to name a few.  The ligand, 1,10-phenanthroline-2,9-dicarboxylate (PDA), was chosen for 
research and crystals of 1,10-phenanthroline-2,9-dicarboxylic acid were synthesized and then 
characterized by NMR and IR to determine their purity.  Titration experiments were performed 
on aqueous solutions of the metal and PDA.  A competing ligand, EDTA, was also introduced to 
the titration experiments and aided in the determination of formation constants, log K1, for metal 
ions with PDA.  UV/Vis spectrophotometry was used as a detection method for the formation of 
metal-PDA complexes.  The log K1 values for metal-PDA complexes were determined from UV 
absorbance data as a function of pH.  Formation constants for metal ions such as Ca(II), Cd(II), 
Zn(II), Gd(III), and Pb(II) are reported, as well as the crystal structure of [Ca(PDA)(H2O)2].  
153Gd(III)-radiolabeling experiments were also performed to indicate the stability of the Gd(III)-
PDA complex.  Overall, these experiments were used to obtain an understanding of the metal ion 
complexes of PDA. 
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INTRODUCTION 
Metals have been known to facilitate vital processes in the human body, so it is no 
surprise that a great deal of medicinal chemistry focuses on the study of metal-ligand design and 
interactions.  Over time, the focus has broadened from approximately 24 essential elements in 
the body to find applications for nonessential elements.  Figure 1 shows a periodic table and 
some uses for nonessential elements.  Common inorganic applications to medicinal practices 
today range from chelation therapy, for the removal of metal ions such as Pb(II) from the body, 
to magnetic resonance imaging (MRI) and radiopharmacology.1  A prime example of a 
nonessential element with applications in medicinal chemistry is Gd(III), which is used 
extensively in MRI contrast agents.  Ligand design plays an important role in selectively 
chelating Gd(III) to prevent its toxic effects in the body by displacement with Zn(II).  The rare-
earth element, Gd(III), has 7 unpaired electrons that allow it to coordinate H2O molecules to its 
inner sphere, which produces a contrast between the 1H-signal of H2O coordinated to Gd(III) and 
the 1H-signal of H2O found naturally in biological fluids.  Since Gd(III) is highly toxic, Gd(III) is 
typically bound to a metal ion selective chelating agent, such as diethylenetriamine pentaacetic 
acid (DTPA), before being introduced to the body.  As a result of this example and many others, 
ligand design efforts have focused mainly on forming complexes of high thermodynamic 
stability, which are selective for a desired metal ion.  The selective binding of a metal ion to a 
ligand is enhanced by the degree of preorganization of the chelate structure.  Donald J. Cram was 
the first to define the concept of preorganization.2  A ligand is more preorganized when it is more 
constrained to be in the conformation required to complex a metal ion.   
Crown ethers3,4 and cryptands5,6 are of the most common and widely studied macrocycles 
that form complexes, typically with alkali metals, of high thermodynamic stability due to their 
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Figure 1:  A diagram of some common uses of metal ions in medicinal chemistry. 
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preorganized conformations.  Macrocycles with extended delocalized systems, such as 
porphyrins, display the highest thermodynamic stability.  The enhanced complex stability of 
these ligands, macrocyclic7 and cryptate8 effects, has been a gateway to the discovery of 
chelating agents with similar binding properties.  The inherent structural rigidity of these 
macrocycles allows them to selectively complex a particular metal ion over others.   
To further enhance metal ion selectivity, coordination number of the desired metal ion to 
be complexed and the types of donor atoms contained within the binding site of the macrocycle 
should be taken into consideration.  In the example of Gd(III) used in contrast agents for NMR, 
the chelating agent should bind Gd(III) effectively and not be displaced by Zn(II) found in the 
body.  Both ethylenediamine tetraacetic acid (EDTA) and DTPA have similar donor atoms 
arranged in much the same way, but only DTPA9 is 
 
used in MRI contrast agents with Gd(III).  The reason lies in that EDTA cannot effectively bind 
Gd(III) over Zn(II) although it has a high formation constant, log K1, of 17.35 for Gd(III) 
because the formation constants are too similar.10  The coordination number for Gd(III) is 9, 
therefore adequate selectivity for Gd(III) is seen for DTPA since there are 8 donor atoms versus 
6 donor atoms for EDTA. 
The ligand, 1,10-phenanthroline-2,9-dicarboxylate (PDA), was investigated to determine 
the binding constants for a variety of metal ions, presented in this thesis.  PDA has a highly 
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preorganized binding site with a fixed radius and is part of a class of ligands called hemicycles.  
Hemicycles bear the same structural rigidity and fixed conformation that most macrocycles do; 
however, unlike macrocycles, the structures contain terminal donor atoms that make them 
acyclic.  Hemicycles also have several advantages such as increased thermodynamic stability, 
given by the macrocyclic effects, and possibly increased kinetic rates that allow for rapid 
metallation and demetallation.  Another important advantage is that hemicycles are typically 
easier to synthesize and less expensive than their macrocyclic counterparts.   
 
METHODS 
 All chemicals and reagents used were of analytical grade and purchased commercially.  
Aqueous metal-ligand solutions were made using deionized (DI) H2O. 
Characterization of ligands and metal-ligand complexes was performed using 1H-NMR 
and FT-IR analysis.  1H-NMR spectra were performed for organic synthesis products using a 
Bruker 400 MHz NMR spectrometer.  All samples for 1H-NMR analysis were prepared and 
referenced in DMSO-d6.  Infrared absorption spectra were taken of all synthesized organic 
products and crystallized metal-ligand complexes using a Polaris IR-10410 FT-IR instrument 
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(Mattson, Inc.) with WinFIRST software.  Samples for FT-IR analysis were prepared as KBr 
pellets.   
UV/Vis absorbance spectra were carried out for aqueous metal-ligand titration 
experiments using a double beam Cary 1E UV/Vis spectrophotometer (Varian, Inc.) and WinUV 
Version 2.00(25) software.  A 1.0 cm quartz flow cell, fitted with a variable flow peristaltic 
pump, was used to refresh the metal-ligand aqueous solution after each titrant addition was made 
to the sample.  A schematic of the flow cell apparatus is shown in Figure 2.  Suitable 
equilibration times after each titrant addition were determined to be between 5 and 8 minutes, 
depending on the metal ion being studied.  Absorbance scan ranges were from 190 to 350 nm at 
a rate of 600.00 nm/min.  All absorbance spectra were referenced using DI H2O and a 1.0 cm 
quartz cell filled with DI H2O was placed in the path of the reference beam.   
All pH values for the titration experiments were recorded using a SympHony SR60IC pH 
meter (VWR Scientific, Inc.), which was calibrated prior to each titration experiment using pH 
4.01, 7.00, and 10.00 buffer solutions.  Aqueous metal-ligand samples used in the titration 
experiments were of 0.10 M NaClO4 for ionic strength and maintained at a constant 25.0 ± 0.1 
°C throughout the experiment.  
Synthesis of PDA 
 The synthesis of PDA was carried out as described in the literature11 with a few 
modifications.  A schematic of the synthesis is shown in Figure 3.  Characterization of the 
products was performed using both 1H-NMR and FT-IR analysis.   
A mixture of 6.008 g of 2,9-dimethyl-1,10-phenanthroline monohydrate (26.55 mmol, 
Alfa Aesar, 99%) and 15.004 g of selenium dioxide (135.22 mmol, Alfa Aesar, 99+%) was 
placed in 400 mL of 4% DI H2O/p-dioxane (Alfa Aesar, 99+%) in a 500 mL round bottom flask.   
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Figure 2:  A schematic of the flow cell apparatus used in the titration experiments. 
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Figure 3:  A schematic of the synthesis of PDA as reported by Chandler et. al.
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The mixture was stirred and allowed to reflux at 101 °C in a wax bath for 3 hours.  The hot 
solution was immediately filtered through a layer of celite (Fisher Scientific) and a yellow-
orange product precipitated from the cold filtrate.  The synthesis yielded 3.460 g of impure 1,10-
phenanthroline-2,9-dicarboxaldehyde (14.65 mmol, 45.5%), which was separated from the 
filtrate by vacuum filtration and allowed to dry.  The dialdehyde product was not taken through 
further purification steps since the next step of the synthesis involved further oxidation. 
 A solution of 3.000 g of non-purified 1,10-phenanthroline-2,9-dicarboxaldehyde (12.70 
mmol) and 60 mL of 4:1 HNO3 (15.8 N, Fisher Scientific)/H2O was placed in a 150 mL round 
bottom flask.  The mixture was stirred while refluxing at 122 °C for 2 hours.  The solution was 
cooled to room temperature and poured over approximately 50 cc of crushed ice.  The 
precipitated 1,10-phenanthroline-2,9-dicarboxylic acid was filtered out by vacuum filtration and 
allowed to dry.  For further purification, the product was recrystallized from methanol and 2.157 
g of 1,10-phenanthroline-2,9-dicarboxylic acid monohydrate (7.535 mmol, 59.3%) was obtained 
as fine, yellow needles. 
 
Titrations Involving PDA 
Acid-base titrations of aqueous metal-PDA solutions were monitored using UV/Vis 
spectrophotometry.  At least two sets of experiments were performed for each metal ion with 
PDA.  The first titration experiment involved the metal with PDA and the second experiment 
used a competing ligand, EDTA or DTPA, with the metal and PDA.   Stock solutions of 
1.00×10-3 M PDA (0.0286 g into 100 mL of 0.0100 M NaOH), 1.00×10-2 M Na2EDTA (0.3722 g 
in 100 mL H2O), and 1.00×10-2 M DTPA (0.3934 g into 100 mL H2O) were used in the titration 
experiments.  Titrant solutions of 0.0100 M HClO4 (10.00 mL of 0.100 M HClO4 in 100 mL DI 
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H2O) in 0.0900 M NaClO4 (1.1020 g in 100 mL DI H2O, Aldrich, 99%) and 0.100 M HClO4 
(6.00 mL of 69-72% HClO4 in 1.00 L H2O, Fisher Scientific) were used to adjust the pH of the 
sample solutions used in the titrations.  The ionic strength of each sample solution was held 
constant with 0.10 M NaClO4 (1.2244 g into 100 mL H2O). 
 
     Solution for titration of PDA 
 In order to determine the protonation constants for PDA, 100 mL of 2.00×10-5 M PDA 
(2.00 mL of 1.00×10-3 M) in 0.10 M NaClO4 was prepared.  A 50.00 ± 0.05 mL aliquot of this 
solution was placed in the flow cell setup described above and titrated with HClO4.  Absorbance 
spectra and pH values were recorded for each titrant addition.  
 
     Solutions for titrations of PDA with Barium(II) 
 A stock solution of 1.00×10-2 M Ba(ClO4)2 (0.3363 g, Aldrich, 97%, Ba(ClO4)2 in 100 
mL of H2O) was prepared for use in both sets of titration experiments.  For the 1:1 Ba(II) and 
PDA titration experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution 
containing 200 µL of 1.00×10-2 M Ba(ClO4)2 and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 
50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus described above 
and titrated with HClO4.  For the ligand competition experiment of 1:1:1 Ba(II), PDA, and 
EDTA, the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M 
Ba(ClO4)2, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were made to a 
100 mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 mL 
sample of the solution was placed in the flow cell apparatus described above and titrated with 
HClO4.   
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     Solutions for titrations of PDA with Cadmium(II) 
A stock solution of 1.00×10-2 M Cd(ClO4)2·H2O (0.3293 g, Aldrich, in 100 mL of H2O) 
was prepared for use in both sets of titration experiments.  For the 1:1 Cd(II) and PDA titration 
experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution containing 200 
µL of 1.00×10-2 M Cd(ClO4)2·H2O and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 
0.05 mL portion of this solution was placed in the flow cell apparatus described above and 
titrated with HClO4.  For the ligand competition experiment of 1:1:1 Cd(II), PDA, and EDTA, 
the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M 
Cd(ClO4)2·H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were made 
to a 100 mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 mL 
sample of the solution was placed in the flow cell apparatus described above and titrated with 
HClO4.   
 
     Solutions for titrations of PDA with Calcium(II) 
A total of three titration experiments were performed to determine the log K1 for Ca(II) 
with PDA.  A stock solution of 1.00×10-2 M Ca(ClO4)2·4H2O (0.3110 g, Aldrich, 99%, in 100 
mL of H2O) was prepared for use in all of the titration experiments.  For the 1:1 Ca(II) and PDA 
titration experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution 
containing 200 µL of 1.00×10-2 M Ca(ClO4)2·4H2O and 2.00 mL of 1.00×10-3 M PDA was 
prepared.  A 50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus 
described above and titrated with HClO4.  For the ligand competition experiment of 1:1:1 Ca(II), 
PDA, and EDTA, the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 
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1.00×10-2 M Ca(ClO4)2·4H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M 
Na2EDTA were made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  
A 50.00 ± 0.05 mL sample of the solution was placed in the flow cell apparatus described above 
and titrated with HClO4.  An additional PDA and EDTA competition experiment for Ca(II) was 
performed for 1:1:10 Ca(II), PDA, and EDTA.  Additions of 200 µL of 1.00×10-2 M 
Ca(ClO4)2·4H2O, 2.00 mL of 1.00×10-3 M PDA, and 2.00 mL of 1.00×10-2 M Na2EDTA were 
made to a 100 mL volumetric flask, which was then filled to the mark.  A 50.00 ± 0.05 mL 
sample of the solution was placed in the flow cell apparatus described above and titrated with 
HClO4. 
 
     Solutions for titrations of PDA with Copper(II) 
A stock solution of 1.00×10-2 M Cu(ClO4)2·6H2O (0.3705 g, Aldrich, in 100 mL of H2O) 
was prepared for use in both sets of titration experiments.  For the 1:1 Cu(II) and PDA titration 
experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution containing 200 
µL of 1.00×10-2 M Cu(ClO4)2·6H2O and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 
0.05 mL portion of this solution was placed in the flow cell apparatus described above and 
titrated with HClO4.  For the ligand competition experiment of 1:1:1 Cu(II), PDA, and EDTA, 
the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M 
Cu(ClO4)2·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were 
made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 
mL sample of the solution was placed in the flow cell apparatus described above and titrated 
with HClO4.   
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     Solutions for titrations of PDA with Gadolinium(III) 
A stock solution of 1.00×10-2 M Gd(NO3)3·6H2O (0.4513 g, Aldrich, 99.9%, in 100 mL 
of H2O) was prepared for use in both sets of titration experiments.  The 1.00×10-2 M 
Gd(NO3)3·6H2O stock solution was adjusted to a pH of 3 using HClO4.  For the 1:1 Gd(III) and 
PDA titration experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution 
containing 200 µL of 1.00×10-2 M Gd(NO3)3·6H2O and 2.00 mL of 1.00×10-3 M PDA was 
prepared.  A 50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus 
described above and titrated with HClO4.  For the ligand competition experiment of 1:1:1 
Gd(III), PDA, and EDTA, the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 
1.00×10-2 M Gd(NO3)3·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M 
Na2EDTA were made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  
A 50.00 ± 0.05 mL sample of the solution was placed in the flow cell apparatus described above 
and titrated with HClO4.   
 
     Solutions for titrations of PDA with Lanthanum(III) 
A total of three titration experiments were performed to determine the log K1 for La(III) 
with PDA.  A stock solution of 1.00×10-2 M La(ClO4)3·6H2O (0.5454 g in 100 mL of H2O) was 
prepared for use in all of the titration experiments.  The 1.00×10-2 M La(ClO4)3·6H2O stock 
solution was adjusted to a pH of 3 using HClO4.  For the 1:1 La(III) and PDA titration 
experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution containing 200 
µL of 1.00×10-2 M La(ClO4)3·6H2O and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 
0.05 mL portion of this solution was placed in the flow cell apparatus described above and 
titrated with HClO4.  For the ligand competition experiment of 1:1:1 La(III), PDA, and EDTA, 
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the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M 
La(ClO4)3·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were 
made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 
mL sample of the solution was placed in the flow cell apparatus described above and titrated 
with HClO4.  An additional experiment using 1:1:1 La(III), PDA, and DTPA was carried out.  
Additions of 200 µL of 1.00×10-2 M La(ClO4)3·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL 
of 1.00×10-2 M DTPA were made to a 100 mL volumetric flask, which was then filled to the 
mark with H2O.  A 50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus 
described above and titrated with HClO4. 
 
     Solutions for titrations of PDA with Lead(II) 
A stock solution of 1.00×10-2 M Pb(ClO4)2·3H2O (0.4603 g, Alfa Aesar, 97%, in 100 mL 
of H2O) was prepared for use in both sets of titration experiments.  For the 1:1 Pb(II) and PDA 
titration experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution 
containing 200 µL of 1.00×10-2 M Pb(ClO4)2·3H2O and 2.00 mL of 1.00×10-3 M PDA was 
prepared.  A 50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus 
described above and titrated with HClO4.  For the ligand competition experiment of 1:1:1 Pb(II), 
PDA, and EDTA, the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 
1.00×10-2 M Pb(ClO4)2·3H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M 
Na2EDTA were made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  
A 50.00 ± 0.05 mL sample of the solution was placed in the flow cell setup described above and 
titrated with HClO4.   
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     Solutions for titrations of PDA with Magnesium(II) 
For the Mg(II) and PDA titration experiment, the concentrations for were 0.0333 and 
2.00×10-5 M, respectively.  A 100 mL solution containing 0.0333 M Mg(ClO4)2·6H2O (1.0932 g) 
and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 0.05 mL portion of this solution was 
placed in the flow cell apparatus described above and titrated with HClO4.  For the ligand 
competition experiment of 1:1:1 Mg(II), PDA, and EDTA, the concentrations for each were 
2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M Mg(ClO4)2·6H2O (0.3315 g into 100 mL 
H2O), 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were made to a 100 
mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 mL sample of 
the solution was placed in the flow cell apparatus described above and titrated with HClO4.   
 
     Solutions for titrations of PDA with Nickel(II) 
A stock solution of 1.00×10-2 M Ni(ClO4)2·6H2O (0.3616 g, Alfa Aesar, in 100 mL of 
H2O) was prepared and used in both sets of titration experiments.  For the 1:1 Ni(II) and PDA 
titration experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution 
containing 200 µL of 1.00×10-2 M Ni(ClO4)2·6H2O and 2.00 mL of 1.00×10-3 M PDA was 
prepared.  A 50.00 ± 0.05 mL portion of this solution was placed in the flow cell apparatus 
described above and titrated with HClO4.  For the ligand competition experiment of 1:1:1 Ni(II), 
PDA, and EDTA, the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 
1.00×10-2 M Ni(ClO4)2·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M 
Na2EDTA were made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  
A 50.00 ± 0.05 mL sample of the solution was placed in the flow cell apparatus described above 
and titrated with HClO4.   
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     Solutions for titrations of PDA with Strontium(II) 
A stock solution of 1.00×10-2 M Sr(ClO4)2 (0.4603 g, Aldrich, in 100 mL of H2O) was 
prepared for use in both sets of titration experiments.  For the 1:1 Sr(II) and PDA titration 
experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution containing 200 
µL of 1.00×10-2 M Sr(ClO4)2 and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 0.05 
mL portion of this solution was placed in the flow cell apparatus described above and titrated 
with HClO4.  For the ligand competition experiment of 1:1:1 Sr(II), PDA, and EDTA, the 
concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M Sr(ClO4)2, 2.00 
mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were made to a 100 mL 
volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 mL sample of the 
solution was placed in the flow cell apparatus described above and titrated with HClO4.   
 
     Solutions for titrations of PDA with Zinc(II) 
A stock solution of 1.00×10-2 M Zn(ClO4)2·6H2O (0.3293 g, Aldrich, in 100 mL of H2O) 
was prepared for use in both sets of titration experiments.  For the 1:1 Zn(II) and PDA titration 
experiment, the concentrations for each were 2.00×10-5 M.  A 100 mL solution containing 200 
µL of 1.00×10-2 M Zn(ClO4)2·6H2O and 2.00 mL of 1.00×10-3 M PDA was prepared.  A 50.00 ± 
0.05 mL portion of this solution was placed in the flow cell apparatus described above and 
titrated with HClO4.  For the ligand competition experiment of 1:1:1 Zn(II), PDA, and EDTA, 
the concentrations for each were 2.00×10-5 M.  Additions of 200 µL of 1.00×10-2 M 
Zn(ClO4)2·6H2O, 2.00 mL of 1.00×10-3 M PDA, and 200 µL of 1.00×10-2 M Na2EDTA were 
made to a 100 mL volumetric flask, which was then filled to the mark with H2O.  A 50.00 ± 0.05 
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mL sample of the solution was placed in the flow cell apparatus described above and titrated 
with HClO4.   
 
Preparation of Crystals Submitted for X-ray Crystallography 
     [Ca(PDA)(H2O)2] crystal preparation 
 The synthesis of [Ca(PDA)(H2O)2] crystals was carried out by dissolving the 0.0709 g 
PDA (0.248 mmol) in n-butanol and 0.0765 g Ca(ClO4)2·4H2O (0.246 mmol) in H2O.  The 
Ca(ClO4)2·4H2O solution was placed into a 30 mm×150 mm test tube in a hot water bath at 
approximately 80 °C.  A layer of n-butanol was then added to the aqueous solution of 
Ca(ClO4)2·4H2O to allow an initial interface between n-butanol and H2O to form.  The n-butanol 
solution of PDA was added carefully to the test tube while hot.  An effort was made to avoid 
disturbing the interface between the two solvents.  After combining the layers, the contents of the 
test tube were left to cool with the hot water bath.  This technique leads to slow diffusion of the 
Ca(II) salt and the ligand together at the interface of the two solvents.  This results in a slow 
crystallization of the otherwise highly insoluble complex, which would otherwise precipitate too 
rapidly and form microcrystals unsuitable for X-ray crystallography. Crystals of 
[Ca(PDA)(H2O)2] accumulated on the interface of the n-butanol/H2O layers and were collected 
by vacuum filtration.  IR analysis and X-ray crystallography experiments were performed on the 
[Ca(PDA)(H2O)2] crystals.    
 
     DMOPA·H2O crystal preparation 
 An impurity of PDA, 2,9-bis(carbomethoxy)-1,10-phenanthroline (DMOPA), was 
determined to be a byproduct of PDA when recrystallized from methanol.  Crystals of DMOPA 
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were recrystallized from n-butanol and collected by vacuum filtration.  IR analysis and X-ray 
crystallography experiments were performed on the DMOPA crystals.   
 
153Gd Radiolabeling of PDA 
 Lihui Wei, David Reichert, and Michael J. Welch at Washington University in St. Louis 
performed the radiolabeling and serum stability studies of 153Gd(III) with PDA.  A 153Gd(III) and 
PDA radiolabeling experiment was performed to ensure that the 153Gd(III)-PDA complex would 
form.  A 4.5×10-3 M solution of PDA was prepared in ethanol.  A mixture of 1.5 µL of 153GdCl3 
in 0.1 M HCl (no-carrier-added, 5.5 µCi) and 8.3 µL of the PDA solution were added to 90 µL of 
0.1 M ammonium acetate for a pH of 7.  The reaction mixture was incubated at 25 °C for 15 
minutes to ensure complexation of 153Gd(III) with PDA.  The formation of a 153Gd(III)-PDA 
complex was confirmed by radio-TLC using ITLC-SG for the stationary phase and ethanol as the 
mobile phase.   
 A competition experiment between PDA and DTPA for 153Gd(III) was conducted to test 
the strength of the 153Gd(III)-PDA complex.  An equimolar concentration of DTPA was added to 
the solution of 153Gd(III)-PDA in ammonium acetate at a pH of 7.  The mixture was allowed to 
equilibrate for 2 days at 25 °C.  The competition experiment was monitored by radio-TLC 
analysis using a mobile phase of 50:50 methanol/10% ammonium acetate on silica gel. 
 A serum stability study of the 153Gd(III)-PDA complex was performed to determine if 
PDA interacts with proteins.  A 10 µL portion of 153Gd(III)-PDA in ammonium acetate with 90 
µL of rat serum was incubated at 37 °C.  The reaction mixture was monitored by radio-TLC 
using a stationary phase of ITLC-SG and a mobile phase of ethanol.   
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RESULTS AND DISCUSSION 
Synthesis of PDA  
The synthesis of 1,10-phenanthroline-2,9-dicarboxaldehyde (PDALD) resulted in an 
impure mixture.  A yield of approximately 45.5% of PDALD was obtained from the synthesis.  
Selenium dioxide was effective for oxidizing 2,9-dimethyl-1,10-phenanthroline monohydrate to 
PDALD, although other oxidation states were also formed.  PDALD was the major product, 
shown by the 1H-NMR spectrum in Figure 4.  The 1H-NMR spectrum showed a peak for the 
aldehyde proton at 10.36 ppm, as well as the aromatic hydrogens on the phenanthroline ring at 
8.30 (H5,6, singlet), 8.32 (H 3,8), and 8.81 (H4,7) ppm.  Chandler, et. al. reports values of 10.45 
ppm for the aldehyde proton and 8.25, 8.30, and 8.75 ppm, respectively, for the aromatic 
hydrogens.  The IR spectrum of PDALD, shown in Figure 5, yielded a C=O stretch for the 
aldehyde at 1704 cm-1.  There was also a peak at 1734 cm-1 that closely matched the C=O stretch 
for 1,10-phenanthroline-2,9-dicarboxylic acid.  A C=O stretch of 1720 cm-1 for PDALD was 
reported by Chandler, et. al., which is not in agreement for the IR data obtained for this 
synthesis.  Since the final product required full oxidation, further purification by recrystallization 
was not performed. 
The objective for the syntheses was to obtain 1,10-phenanthroline-2,9-dicarboxylic acid.  
[PDA]H2 was obtained from the oxidation of PDALD by 4:1 HNO3/H2O, with the impure 
[PDA]H2 being purified by recrystallization from methanol.  A yield of 59.3% was achieved for 
the final product, PDA.  The melting point of the fine, yellow needles was 219.3 °C, compared to 
the literature value11 of 231-232 °C.  Despite the lowered melting point, 1H-NMR and IR 
analysis produced clean spectra for the [PDA]H2 crystals.  The 1H-NMR spectrum, shown in 
Figure 6, produced two sets of doublets at 8.42 ppm (H-3,8) and 8.74 ppm (H-4,7) and one  
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Figure 4:  The 1H-NMR spectrum of impure 1,10-phenanthroline-2,9-dicarboxaldehyde in 
DMSO-d6. 
 20
 
Figure 5:  The IR spectrum of 1,10-phenanthroline-2,9-dicarboxaldehyde. 
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Figure 6:  The 1H-NMR spectrum of 1,10-phenanthroline-2,9-dicarboxylic acid in DMSO-d6. 
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singlet at 8.22 ppm (H-5,6).  Chandler, et. al. reported peak positions of 8.45, 8.75, and 8.20 ppm 
for [PDA]H2, respectively, which are in close agreement with the values obtained for this 
experiment.  The [PDA]H2 was a monohydrate, so a peak for H2O at 3.17 ppm was also seen.  
This was confirmed by the IR spectrum, where a peak for water was seen at 3384 cm-1. Figure 7 
shows the IR spectrum of [PDA]H2 with peaks of 1739 cm-1 for the C=O stretch and 3079 cm-1 
for the O-H of the carboxylic acid.  The 1H-NMR and IR spectra confirmed that PDALD had 
been successfully converted to [PDA]H2.  All of the solutions used in the titration experiments 
and the synthesis of [Ca(PDA)(H2O)2] crystals were prepared from these crystals of [PDA]H2.   
 
Titrations Involving PDA 
 
The titration experiments were performed utilizing UV/Vis spectroscopy as an analytical 
tool to detect metal complex formation involving PDA.  Absorbance scans were performed from 
190 to 350 nm for each titrant addition of HClO4.  Absorbance data were taken at selected 
wavelengths of 226, 235, 246, 280, and 286 nm.  Absorbance maxima were shown at 235 and 
280 nm for the free PDA. Upon complexation of PDA with a metal ion, a new peak at 246 nm 
was observed, as well as a peak shift from 280 to 286 nm. The presence of the 246 nm peak 
came to be regarded as diagnostic of the metal-ligand complex formation. 
In order to determine the protonation constants for the ligand, PDA, a titration 
experiment was performed at 25.0 ± 0.1 °C in 0.10 M NaClO4 for ionic strength.  Figure 8 shows 
absorbance versus wavelength (nm) for the titration of PDA.  Absorbance data from 226 nm was 
used to generate the plot of absorbance versus pH.  The best plot was seen from the data taken at 
226 nm for the absorbance spectra.  The protonation constants for PDA were calculated using the 
absorbance data and pH values from this plot.  Although sodium is typically an inert metal ion 
when introduced to a ligand, a log K1 of 1.84 for sodium with EDTA was estimated from other  
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Figure 7:  The IR spectrum of 1,10-phenanthroline-2,9-dicarboxylic acid monohydrate. 
 24
 
 
 
 
 
 
Figure 8:  The absorbance versus wavelength (nm) spectra from the titration experiment 
conducted at 25.0 ± 0.1 °C for PDA in 0.10 M NaClO4 for ionic strength. 
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reported pK backgrounds.10 The corrected protonation constants of pK1, pK2, and pK3 for PDA 
were 4.75, 3.71, and 2.09, respectively.   The species distribution diagram of PDA, shown in 
Figure 9, gives the fraction of LH3, LH2, LH, and L relative to pH, where L is the dicarboxylate 
form of PDA.  An illustration of the protonation events for PDA is shown in Figure 10.  The 
third protonation event, pK3, for PDA was difficult to see in most of the plots for absorbance 
versus pH due to the limits of the pH electrode.  However, the absorbance data at 226 nm was 
the most useful for determining pK3.   
 
Titrations Involving Metals with PDA 
At least two sets of titration experiments were performed for the determination of log K1 for each 
metal ion.  The first titration experiment yielded absorbance values as a function of pH for the 
metal ion with PDA.  The protonation constants for PDA were determined to be fairly low, and it 
is therefore difficult to drive the metal from a PDA complex by conducting a direct titration 
experiment with acid, considering the high log K1 values that metal ions exhibit with PDA.  In 
order to solve this dilemma, a second titration experiment was implemented to drive a metal ion 
from the EDTA complex into the PDA complex.  EDTA is a hexadentate ligand that has log K1 
values that are only slightly higher than the tetradentate ligand, PDA.  The equilibrium being 
studied is given by Equation (1). 
           Mn+(EDTA)4- + PDA2- + H+  Mn+(PDA)2- + [(EDTA)H]3- (1) 
This equation shows the exchange equilibrium of the metal ion between PDA and EDTA as a 
function of pH.  The equilibrium was easily studied by monitoring absorbance since EDTA does 
not have a strong absorption band in the UV region.  The titration experiment provided 
absorbance values as a function of pH for the competition of EDTA and PDA for the metal ion.   
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Figure 9:  The protonated species distribution diagram for PDA with respect to pH. 
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Figure 10:  A diagram showing the three protonation events of PDA 
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As the pH of the solution is lowered, a transition was observed where Equation (1) shifts from 
left to right.  The pK1, first protonation constant, for EDTA is 9.52 at an ionic strength of 0.10 M 
NaClO4.10  PDA is a weaker proton base and has a much lower pK1 at 4.75 for an ionic strength 
of 0.10 M NaClO4.  These large differences in pK1 values allow PDA to complex the metal ion 
strongly at lower pH values relative to EDTA.  The direct titration experiment of PDA with the 
metal ion was used only as a reference for competition reactions involving PDA and EDTA with 
a metal ion.   
For each titration experiment, absorbance values were monitored as a function of pH.  At 
every absorbance scan, pH values were also recorded and plotted as corrected absorbance versus 
pH using EXCEL.  Using Equation (2), recorded absorbance values were corrected for dilution 
after each addition of titrant. 
 
initial
total
V
V · Absorbance
  Absorbance Corrected =  (2) 
Both plots of the PDA with the metal ion and the PDA and EDTA competition experiment with 
the metal ion were overlaid in EXCEL.  The absorbances of the two plots were similar at lower 
pH values, where only the PDA complex existed.  For the PDA and EDTA competition 
experiment with the metal ion, a crossover from the EDTA complex at higher pH values to the 
PDA complex at lower pH values was observed.  This crossover produced a slope for which a 
pH50 value was calculated.  The pH50 value is an inflection point in the slope where an equal 
distribution of the metal ion exists between the PDA and EDTA.  In order to obtain the pH50, pH 
and absorbance values were selected for the slope found from the plot of the competition 
experiment between PDA and EDTA for the metal ion.  An n  observed calculation was 
performed for the slope using Equation (3). 
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iniinf
ini
Abs - Abs
Abs - Abs  =observedn  (3) 
The total ligand concentration, [L]total, in the sample solution was also calculated using Equation 
(4). 
 [ ] [ ]
total
iniini
total V
V ·  L   L =  (4) 
After the n  values and the total ligand concentrations were known, the distribution between the 
complexed ligand, [ML] and the free ligand, [L], was calculated using Equations (5) and (6). 
 [ ] [ ] total L ·   ML observedn=  (5) 
 [ ] [ ] [ ]ML -  L  L total=  (6) 
The total hydrogen ion concentration, [H+], in the sample solution was calculated using Equation 
(7). 
 [ ] -pH10  H =+  (7) 
The values obtained from Equations (5), (6), and (7) were used to calculate pH50 in Equation (8), 
where L1 is PDA and L2 is EDTA or DTPA. 
 [ ][ ][ ][ ][ ]+= HLML
HLML  pH
12
21
50  (8) 
Finally, the stability constant, log K1, for each metal ion with PDA was calculated using 
Equation (9). 
 50111 pH  (EDTA) p - (EDTA)  log  (PDA)  log += KKK  (9) 
 
Molecular modeling of metal ions with ionic radii of approximately 1.0 Å were shown to 
reduce the steric strain on PDA, and thus reduce the overall energy of the complex.  The opposite 
effect occurs with smaller metal ions, such as Mg(II), and larger metal ions, such as Ba(II), 
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which distort the rigid structure of PDA.  Molecular mechanics (MM+) calculations were 
performed for metal ions with PDA and a plot of energy (kcal·mol-1) versus metal-oxygen bond 
length (Å) was generated, which is illustrated in Figure 11.  The stability constants, log K1, for 
metals with PDA from the titration experiments complemented the results obtained from the 
MM+ calculations.  This shows an enhanced complex stability with metals of an ionic radius of 
approximately 1.0 Å.   
The log K1 results for metal ions with PDA were determined from absorbance data and 
corresponding pH values taken from the EDTA and PDA competition experiments with metal 
ions using Equations (1-9) shown above.  Ethylenediamine dicarboxylic acid (EDDA) is the 
unpreorganized precursor to PDA, so the log K1 results for PDA with the metal ions were 
compared to EDDA.  The log K1 values for PDA with the metal ions used in the titrations are 
displayed in Table 1, as well as the log K1 values for EDDA with metal ions.10  Also, Δ log K1 
between PDA and EDDA was calculated for each metal ion used and displayed in Table 1.   
 
     Barium(II)-PDA results 
 Ba(II) has an ionic radius of 1.36, which is slightly larger than the target radius of 
1.0 Å for PDA.  The UV absorbance spectra are shown in Figure 12 for the titration of Ba(II) 
with PDA.  A example plot of corrected absorbance versus pH for Ba(II) is shown in Figure 13.  
Also, the observed and calculated n  versus pH plots are shown in Figure 14.  From the selected 
wavelengths described above, a log K1 of 5.50 was calculated from the absorbance data using 
Equations (1-9).  The reported formation constant for EDDA with Ba(II) was 3.3, which was 
weaker when compared to the log K1 for that of PDA with Ba(II).  A Δ log K1 of 2.20 between 
the log K1 values of PDA and EDDA with Ba(II) was calculated and showed a slight increase in  
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Figure 11:  The calculated strain energy (kcal·mol-1) versus metal-oxygen bond length (Å) for 
Mn+-PDA complexes using Hyperchem embedded MM+ calculations. 
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Table 1:  The comparison of log K1 data for metal ions with PDA and EDDA 
 
Metal Ion Ionic Radius (Å) log K 1 (PDA) log K 1 (EDDA)10 Δ log K
Mg2+ 0.74 3.30 4.0 -0.70
Ca2+ 1.00 7.72 4.0 3.72
Sr2+ 1.18 5.60 3.6 2.00
Ba2+ 1.36 5.50 3.3 2.20
Pb2+ 1.19 12.62 10.6 2.02
La3+ 1.03 13.40 7.0 6.40
Gd3+ 0.93 14.84 8.1 6.74
Cd2+ 0.95 12.87 9.1 3.77
Zn2+ 0.74 11.63 11.1 0.53
Ni2+ 0.69 12.73 13.6 -0.87
Cu2+ 0.57 13.70 16.2 -2.50  
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a.) 
 
b.) 
Figure 12:  The UV absorbance spectra for the titration of (a) 1:1 Ba(II) and PDA and (b) 1:1:1 
Ba(II), PDA, and EDTA  
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Figure 13:  The combined 246 nm corrected absorbance data versus pH from titration 
experiments involving Ba(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 14:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 226 nm, b.) 235 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Ba(II). 
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stability of the PDA complex of Ba(II) relative to the EDDA complex of Ba(II). 
 
     Cadmium(II)-PDA results 
 Cd(II) has an ionic radius of 0.95, which is almost ideal to span the region between the 
carboxylate groups of PDA.  The UV absorbance spectra are shown in Figure 15 for the titration 
of Cd(II) with PDA.  A example plot of corrected absorbance versus pH for Cd(II) is shown in 
Figure 16.  Also, the observed and calculated n  versus pH plots are shown in Figure 17.  From 
the selected wavelengths described above, a log K1 of 12.87 was calculated for Cd(II) with PDA 
using Equations (1-9).  When compared to the log K1 of EDDA, which is 9.1, PDA showed an 
increase in complex stability.  A Δ log K1 of 3.77 quantified the difference in stability of the 
PDA complex versus the EDDA complex of Cd(II). 
 
     Calcium(II)-PDA results 
 The ionic radius of Ca(II) is 1.00 Å, which allows a suitable fit between the carboxylate 
groups of PDA.  The UV absorbance spectra are shown in Figure 18 for the titration of Ca(II) 
with PDA.  A example plot of corrected absorbance versus pH for Ca(II) is shown in Figure 19.  
Also, the observed and calculated n  versus pH plots are shown in Figure 20.  From the selected 
wavelengths described above, a log K1 of 7.72 was calculated from the absorbance data for 
Ca(II) with PDA using Equations (1-9).  This showed an enhanced complex stability when 
compared to EDDA.  The reported formation constant for EDDA is 4.0 for Ca(II) and the Δ log 
K1 for the PDA complex versus the EDDA complex of Ca(II) is 3.72. 
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a.) 
 
b.)  
Figure 15:  The UV absorbance spectra for the titration of (a) 1:1 Cd(II) and PDA and (b) 1:1:1 
Cd(II), PDA, and EDTA  
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Figure 16:  The combined 235 nm corrected absorbance data versus pH from titration 
experiments involving Cd(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 17:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 286 nm for the competition of PDA and EDTA 
for Cd(II). 
 40
  
 
 
 
a.) 
 
b.)  
Figure 18:  The UV absorbance spectra for the titration of (a) 1:1 Ca(II) and PDA and (b) 1:1:1 
Ca(II), PDA, and EDTA  
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Figure 19:  The combined 235 nm corrected absorbance data versus pH from titration 
experiments involving Ca(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
Figure 20:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 246 nm and b.) 280 nm for the competition of PDA and EDTA for Ca(II). 
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     Copper(II)-PDA results 
 The ionic radius of Cu(II) is 0.57 Å, which is far below the target ionic radius of 1.0 Å 
for PDA.  The UV absorbance spectra are shown in Figure 21 for the titration of Cu(II) with 
PDA.  A example plot of corrected absorbance versus pH for Ba(II) is shown in Figure 22.  Also, 
the observed and calculated n  versus pH plots are shown in Figure 23.  From the selected 
wavelengths described above, a log K1 of 13.70 for Cu(II) with PDA was calculated from the 
absorbance data using Equations (1-9).  The reported formation constant for EDDA with Cu(II) 
is 16.2, which is stronger when compared to the log K1 for that of PDA with Cu(II).  A Δ log K1 
of –2.50 between the log K1 values of PDA and EDDA with Cu(II) was calculated and showed 
the lack of stability of the PDA complex of Cu(II) relative to the EDDA complex of Cu(II).   
 
     Gadolinium(III)-PDA results 
 The ionic radius of Gd(III) is 0.93 Å, which is relatively close to the ideal ionic radius of 
1.0 Å for PDA.  The UV absorbance spectra are shown in Figure 24 for the titration of Gd(III) 
with PDA.  A example plot of corrected absorbance versus pH for Gd(III) is shown in Figure 25.  
Also, the observed and calculated n  versus pH plots are shown in Figure 26.  From the selected 
wavelengths described above, a log K1 of 14.84 was calculated from the absorbance data for 
Gd(III) with PDA using Equations (1-9).  The reported formation constant for EDDA is 8.1 with 
Gd(III), which yields a Δ log K1 of 6.74 when compared with the log K1 for PDA with Gd(III).  
The benefits of preorganization may be seen from this overwhelming difference in log K1 
between PDA and EDDA for Gd(III). 
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a.) 
 
b.) 
Figure 21:  The UV absorbance spectra for the titration of (a) 1:1 Cu(II) and PDA and (b) 1:1:1 
Cu(II), PDA, and EDTA 
 
 45
 
 
 
 
 
 
 
 
 
 
Figure 22:  The combined 246 nm corrected absorbance data versus pH from titration 
experiments involving Cu(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 23:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Cu(II). 
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a.) 
 
b.) 
Figure 24:  The UV absorbance spectra for the titration of (a) 1:1 Gd(III) and PDA and (b) 1:1:1 
Gd(III), PDA, and EDTA  
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Figure 25:  The combined 280 nm corrected absorbance data versus pH from titration 
experiments involving Gd(III).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 26:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 226 nm, b.) 235 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Gd(III). 
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     Lanthanum(III)-PDA results 
 The ionic radius of La(III) is 1.03 Å, which is only slightly higher than the preferred 1.0 
Å for PDA.  PDA had a much higher affinity for La(III) than did EDTA, so DTPA was 
substituted as the competing ligand for the titration experiment.  The ability of the tetradentate 
ligand, PDA, to compete effectively with the octadentate ligand, DTPA, is due to the 
preorganized structure of PDA.  The UV absorbance spectra are shown in Figure 27 for the 
titration of La(III) with PDA.  A example plot of corrected absorbance versus pH for La(III) is 
shown in Figure 28.  Also, the observed and calculated n  versus pH plots are shown in Figure 
29.  From the selected wavelengths described above, a log K1 of 13.40 was calculated for La(III) 
with PDA using Equations (1-9).  Comparitively, the log K1 for La(III) with EDDA is 7.0, which 
gives a  Δ log K1 of 6.40 when compared with the log K1 for PDA with La(III).  The difference in 
log K1 values of PDA versus EDDA for La(III) showed a remarkable increase in stability for the 
preorganized structure of PDA with La(III).   
 
     Lead(II)-PDA results 
 The ionic radius of Pb(II) is 1.19 Å, which is slightly above the preferred 1.0 Å for PDA.  
The UV absorbance spectra is shown in Figure 30 for the titration of Pb(II) with PDA.  A 
example plot of corrected absorbance versus pH for Pb(II) is shown in Figure 31.  Also, the 
observed and calculated n  versus pH plots are shown in Figure 32.  A charge transfer band for 
Pb(II) was seen in the UV absorbance spectra at approximately 230 nm.  This may have 
interfered with the absorbance data taken at 226 nm.  A log K1 of 12.62 was calculated using 
Equations (1-9) for Pb(II) with PDA from the absorbance data at the wavelengths mentioned 
above, excluding the absorbance data taken at 226 nm.  An increase in complex stability is seen 
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a.)  
 
b.) 
Figure 27:  The UV absorbance spectra for the titration of (a) 1:1 La(III) and PDA and (b) 1:1:1 
La(III), PDA, and DTPA  
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Figure 28:  The combined 235 nm corrected absorbance data versus pH from titration 
experiments involving La(III).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
 
b.) 
 
c.) 
 
Figure 29:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 280 nm for the competition of PDA and DTPA 
for La(III). 
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a.) 
 
b.)  
Figure 30:  The UV absorbance spectra for the titration of (a) 1:1 Pb(II) and PDA and (b) 1:1:1 
Pb(II), PDA, and EDTA  
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Figure 31:  The combined 246 nm corrected absorbance data versus pH from titration 
experiments involving Pb(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 32:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Pb(II). 
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for Pb(II) and PDA with respect to EDDA.  A log K1 of 10.6 for Pb(II) with EDDA was reported 
and the Δ log K1 between PDA and EDDA for Pb(II) was determined to be 2.02.  Due to the 
larger ionic radius of Pb(II), the difference in stability constants for the PDA complex versus the 
EDDA complex was not as pronounced.   
 
     Magnesium(II)-PDA results 
 The ionic radius of Mg(II) is 0.74 Å, which is far below the target ionic radius of a metal 
ion for a PDA complex.  Due to the large cavity size of PDA, the smaller Mg(II) metal ion 
struggles to bridge the gap between the carboxylate groups.  Therefore, an enhanced complex 
stability was not seen for the Mg(II) metal ion with PDA relative to the EDDA complex with 
Mg(II).  The competition experiment between PDA and EDTA for Mg(II) reveals that the Mg(II) 
never formed a complex with PDA in the presence of EDTA.  The UV absorbance spectra are 
shown in Figure 33 for the titration of Mg(II) with PDA.   A example plot of corrected 
absorbance versus pH for Mg(II) is shown in Figure 34.  From the selected wavelengths 
described above, a log K1 for Mg(II) with PDA was 3.30.  The reported value of EDDA with 
Mg(II) was 4.0.  The similarities between the log K1 values for PDA and EDDA with Mg(II) 
suggested that the increase in strain energy for PDA to complex Mg(II) resulted in an overall 
decrease for log K1.   
 
     Nickel(II)-PDA results 
 The ionic radius of Ni(II) is 0.69, which is below the preferred ionic radius of 1.0 Å for 
PDA.  The Ni(II)PDA complex is destabilized because Ni(II) cannot adequately span the gap 
between the carboxylate groups of PDA.  Therefore, PDA compensates for this lack of ionic  
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a.) 
 
b.) 
 
Figure 33:  The UV absorbance spectra for the titration of (a) 1:1 Mg(II) and PDA and (b) 1:1:1 
Mg(II), PDA, and EDTA 
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Figure 34:  The combined 226 nm corrected absorbance data versus pH from titration 
experiments involving Mg(II).  The sample solution used for the titration of Mg(II) and PDA 
contained 0.0333 M Mg(II).  The titration of PDA at this wavelength is also shown for reference. 
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radius by adjusting its rigid structure to accommodate the Ni(II) metal ion.  The UV absorbance 
spectra are shown in Figure 35 for the titration of Ni(II) with PDA.  An example plot of 
corrected absorbance versus pH for Ni(II) is shown in Figure 36.  Also, the observed and 
calculated n  versus pH plots are shown in Figure 37.  From the selected wavelengths described 
above, a log K1 of 12.73 was calculated for PDA with Ni(II), which was slightly lower than the 
log K1 reported formation constant of 13.6 for EDDA with Ni(II).  A Δ log K1 between PDA and 
EDDA with Ni(II) was –0.87, which suggested that there is an increase in the overall strain 
energy for the PDA complex of Ni(II). 
 
     Strontium(II)-PDA results 
 The ionic radius of Sr(II) is 1.18 Å, which is slightly higher than the target ionic radius of 
1.0 Å for PDA.  The UV absorbance spectra are shown in Figure 38 for the titration of Sr(II) 
with PDA.  A example plot of corrected absorbance versus pH for Sr(II) is shown in Figure 39.  
Also, the observed and calculated n  versus pH plots are shown in Figure 40.  From the selected 
wavelengths described above, a log K1 of 5.60 was calculated from the absorbance data for PDA 
with Sr(II) using Equations (1-9) and compared with the reported value of 3.6 for EDDA with 
Sr(II).  The Δ log K1 between the PDA and EDDA for Sr(II) was 2.0, which shows an increase in 
the complex stability for PDA with Sr(II) relative to the EDDA complex with Sr(II).  Due to the 
larger ionic radius of Sr(II), the difference in stability constants for the PDA complex versus the 
EDDA complex was not as pronounced.   
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a.) 
 
b.)  
Figure 35:  The UV absorbance spectra for the titration of (a) 1:1 Ni(II) and PDA and (b) 1:1:1 
Ni(II), PDA, and EDTA  
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Figure 36:  The combined 246 nm corrected absorbance data versus pH from titration 
experiments involving Ni(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 37:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Ni(II). 
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a.) 
 
b.) 
Figure 38:  The UV absorbance spectra for the titration of (a) 1:1 Sr(II) and PDA and (b) 1:1:1 
Sr(II), PDA, and EDTA 
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Figure 39:  The combined 235 nm corrected absorbance data versus pH from titration 
experiments involving Sr(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
b.) 
 
c.) 
 
Figure 40:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 286 nm for the competition of PDA and EDTA 
for Sr(II). 
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     Zinc(II)-PDA results 
 The ionic radius of Zn(II) is 0.74, which is below the preferred ionic radius of 1.0 Å for a 
PDA complex.  The UV absorbance spectra are shown in Figure 41 for the titration of Zn(II) 
with PDA.  A example plot of corrected absorbance versus pH for Zn(II) is shown in Figure 42.  
Also, the observed and calculated n  versus pH plots are shown in Figure 43.  From the selected 
wavelengths described above, a log K1 of 11.63 was calculated from the absorbance data for 
PDA with Zn(II) using Equations (1-9) and compared with the reported value of 11.1 for EDDA 
with Zn(II).  The Δ log K1 between the PDA and EDDA complexes of Zn(II) was 0.53, which 
shows a slight increase in the overall stability of the PDA complex relative to the EDDA 
complex with Zn(II). 
 
Crystal Structure Results 
 Crystal structures of Co(II)12, Mg(II)13, and Ni(II)14 have been reported for PDA.  The 
crystal structures of [Co(PDA)2]2-, [Mg(PDA)(H2O)3], and [Ni(PDA)(H2O)3] are shown in 
Figures 44, 45, and 46, respectively.  The PDA crystal structure Mg(II) shows a slightly better fit 
for the metal ion into PDA, whereas Co(II) must coordinate between a neutral nitrogen and a 
negative oxygen donor of two separate PDA molecules.  This shows the effect that ionic radius 
and coordination number of a metal ion has when a complex of PDA is formed.  Smaller metal 
ions, like Ni(II), have difficulty filling the space between the carboxylate groups of PDA.  Even 
though a small metal ion may complex PDA, a greater strain is placed on the PDA complex in 
order to accommodate the metal ion’s ionic radius.  Therefore, optimal stabilization may be 
obtained by selecting a metal ion with an ionic radius of approximately 1.0 Å for PDA. 
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a.) 
 
b.) 
Figure 41:  The UV absorbance spectra for the titration of (a) 1:1 Zn(II) and PDA and (b) 1:1:1 
Zn(II), PDA, and EDTA 
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Figure 42:  The combined 280 nm corrected absorbance data versus pH from titration 
experiments involving Zn(II).  The titration of PDA at this wavelength is also shown for 
reference. 
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a.) 
 
 
b.) 
 
c.) 
 
Figure 43:  The comparison of n  observed versus n  calculated with respect to pH at 
wavelengths of a.) 235 nm, b.) 246 nm, and c.) 280 nm for the competition of PDA and EDTA 
for Zn(II). 
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Figure 44:  The crystal structure of the [Co(PDA)2]2- complex.12 
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Figure 45:  The crystal structure of the [Mg(PDA)(H2O)3] complex.13 
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Figure 46:  The crystal structure of the [Ni(PDA)(H2O)3] complex.14 
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     [Ca(PDA)(H2O)2] crystal structure 
 The crystal synthesis of [Ca(PDA)(H2O)2] yielded fine, yellow crystals on the interface 
of the n-butanol/H2O layers.  An IR analysis, illustrated in Figure 47, was performed on the 
crystals and referenced to PDA to show the differences in IR spectra.  The crystal structure of  
[Ca(PDA)(H2O)2] consisted of a Ca(II) metal ion coordinated to the two negative oxygen donors 
of the carboxylate groups, two neutral nitrogen donors of the phenanthroline moiety, two waters, 
and both oxygens of a neighboring carboxylate group of PDA, as shown in Figure 48.  
Therefore, Ca(II) was eight-coordinate and the [Ca(PDA)(H2O)2] complex was of a polymeric 
formation, since there was a bridge between a carboxylate group of a neighboring unit cell.  The 
crystal data and structural refinement parameters for the [Ca(PDA)(H2O)2] complex are listed in 
Table 2.  Also, the spatial coordinates of the atoms for the [Ca(PDA)(H2O)2] complex are given 
in Tables 3 and 4.   
 The bond distances for the [Ca(PDA)(H2O)2] complex are displayed in Table 5.  Each 
unit cell of the crystal contained a Ca(II) ion positioned among the four donor atoms of PDA.  
The bond distance between the Ca(II) and nitrogens of PDA were 2.550 and 2.555 Å, which 
were longer bonds than that for the carboxylate groups of the PDA.  The Ca(II) and carboxylate 
oxygen bond distances from PDA were 2.468 and 2.462 Å.  Both oxygens of the neighboring 
carboxylate group of another [Ca(PDA)(H2O)2] unit cell was also coordinated to the Ca(II).  
These Ca(II) and oxygen bond distances were much longer at 2.638 and 2.524 Å.  Two H2O 
molecules were also coordinated to the Ca(II) metal ion, which had Ca(II) and oxygen bond 
distances of 2.410 and 2.387 Å.   
 A list of bond angles for the [Ca(PDA)(H2O)2] complex are given in Table 6.  The bond 
angles of N(2)-C(11)-C(14) and O(3)-C(14)-C(11) for the carboxylate groups were 113.0° and  
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Figure 47:  The IR spectrum of [Ca(PDA)(H2O)2] crystals with the IR spectrum of PDA as a 
reference. 
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Figure 48:  The crystal structure and atom assignments for the [Ca(PDA)(H2O)2)] complex. 
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Table 2:  The crystal data and structure refinement for the [Ca(PDA)(H2O)2] complex. 
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Table 3:  The atomic coordinates (×104) and equivalent isotropic displacement parameters 
(Å2×103) for [Ca(PDA)].  U(eq) is defined as one third of the trace of the orthoganalized Uij 
tensor. 
 
x y z U(eq)
Ca(1) -320(1) 2941(1) 8104(3) 33(1)
O(1) 406(2) 1408(4) 201(9) 43(2)
O(8A) 37(3) 4259(9) 3170(20) 43(4)
O(8B) 86(3) 4365(8) 4520(20) 50(4)
O(2) 709(2) 996(4) -2017(10) 44(2)
O(3) 146(1) 2651(3) 5940(12) 45(2)
O(7) 136(3) 4757(8) 8310(20) 55(4)
O(5) -396(2) 1748(5) 7047(12) 59(2)
O(6) -344(1) 3969(3) 10000(9) 36(2)
O(4) 230(1) 3303(3) 8440(10) 38(2)
N(1) 871(2) 1849(4) 2169(10) 31(2)
N(2) 731(1) 2498(4) 5310(9) 24(2)
C(1) 662(2) 1277(5) -524(14) 34(2)
C(2) 939(2) 1525(4) 583(12) 30(2)
C(3) 1230(2) 1424(6) -35(14) 38(2)
C(4) 1471(2) 1648(5) 1047(13) 35(2)
C(5) 1418(2) 1975(5) 2754(11) 25(2)
C(6) 1649(2) 2220(5) 3951(14) 36(2)
C(7) 1575(2) 2526(4) 5617(12) 29(2)
C(8) 1267(2) 2635(5) 6131(12) 28(2)
C(9) 1181(2) 2964(5) 7758(13) 34(2)
C(10) 873(2) 3076(5) 8123(15) 29(2)
C(11) 661(2) 2827(5) 6872(13) 32(2)
C(12) 1032(2) 2409(5) 4971(13) 31(2)
C(13) 1107(2) 2062(5) 3194(15) 32(2)
C(14) 316(2) 2948(6) 7109(15) 42(3)
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Table 4:  The hydrogen coordinates (×104) and isotropic displacement parameters (Å2×103) for 
the [Ca(PDA)(H2O)2] complex. 
 
x y z U(eq)
H(3) 1266 1201 -1205 45
H(4) 1676 1579 625 42
H(6) 1859 2174 3601 44
H(7) 1733 2668 6445 34
H(9) 1332 3114 8630 41
H(10) 810 3320 9218 35
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Table 5:  The bond lengths (Å) for the [Ca(PDA)(H2O)2] complex. 
 
Bond Bond Length (Å) Bond Bond Length (Å)
Ca(1)-O(6) 2.387(7) N(1)-Ca(1)#2 2.550(8)
Ca(1)-O(5) 2.410(8) N(2)-C(11) 1.328(11)
Ca(1)-O(3)#1 2.462(8) N(2)-C(12) 1.357(11)
Ca(1)-O(1)#1 2.468(7) N(2)-Ca(1)#2 2.555(7)
Ca(1)-O(4) 2.524(7) C(1)-C(2) 1.534(12)
Ca(1)-N(1)#1 2.550(8) C(2)-C(3) 1.370(13)
Ca(1)-N(2)#1 2.555(7) C(3)-C(4) 1.386(13)
Ca(1)-O(3) 2.638(7) C(4)-C(5) 1.402(12)
Ca(1)-C(14) 2.890(10) C(5)-C(13) 1.415(12)
O(1)-C(1) 1.265(12) C(5)-C(6) 1.417(13)
O(1)-Ca(1)#2 2.468(7) C(6)-C(7) 1.379(13)
O(8A)-O(8B) 1.025(19) C(7)-C(8) 1.417(12)
O(2)-C(1) 1.223(12) C(8)-C(9) 1.387(13)
O(3)-C(14) 1.263(13) C(8)-C(12) 1.400(13)
O(3)-Ca(1)#2 2.462(8) C(9)-C(10) 1.398(12)
O(7)-O(7)#3 1.51(3) C(10)-C(11) 1.382(13)
O(4)-C(14) 1.236(13) C(11)-C(14) 1.545(13)
N(1)-C(2) 1.337(12) C(12)-C(13) 1.482(14)
N(1)-C(13) 1.340(12)
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Table 6:  The bond angles (deg) for the [Ca(PDA)(H2O)2] complex. 
Angle Bond Angle (deg) Angle
Bond Angle 
(deg)
O(6)-Ca(1)-O(5) 160.4(3) C(14)-O(4)-Ca(1) 94.2(6)
O(6)-Ca(1)-O(3)#1 84.6(2) C(2)-N(1)-C(13) 116.2(8)
O(5)-Ca(1)-O(3)#1 83.2(3) C(2)-N(1)-Ca(1)#2 120.9(6)
O(6)-Ca(1)-O(1)#1 94.3(2) C(13)-N(1)-Ca(1)#2 122.9(6)
O(5)-Ca(1)-O(1)#1 100.2(3) C(11)-N(2)-C(12) 116.0(8)
O(3)#1-Ca(1)-O(1)#1 170.7(2) C(11)-N(2)-Ca(1)#2 121.4(6)
O(6)-Ca(1)-O(4) 76.5(2) C(12)-N(2)-Ca(1)#2 122.6(6)
O(5)-Ca(1)-O(4) 114.8(2) O(2)-C(1)-O(1) 127.1(9)
O(3)#1-Ca(1)-O(4) 75.3(2) O(2)-C(1)-C(2) 117.4(9)
O(1)#1-Ca(1)-O(4) 95.4(2) O(1)-C(1)-C(2) 115.4(8)
O(6)-Ca(1)-N(1)#1 89.0(2) N(1)-C(2)-C(3) 123.7(9)
O(5)-Ca(1)-N(1)#1 85.9(3) N(1)-C(2)-C(1) 114.3(8)
O(3)#1-Ca(1)-N(1)#1 126.0(2) C(3)-C(2)-C(1) 122.0(9)
O(1)#1-Ca(1)-N(1)#1 63.1(2) C(2)-C(3)-C(4) 119.2(9)
O(4)-Ca(1)-N(1)#1 153.4(2) C(3)-C(4)-C(5) 120.4(9)
O(6)-Ca(1)-N(2)#1 82.7(2) C(4)-C(5)-C(13) 114.3(8)
O(5)-Ca(1)-N(2)#1 78.1(3) C(4)-C(5)-C(6) 124.4(8)
O(3)#1-Ca(1)-N(2)#1 63.2(2) C(13)-C(5)-C(6) 121.3(8)
O(1)#1-Ca(1)-N(2)#1 125.9(2) C(7)-C(6)-C(5) 120.2(8)
O(4)-Ca(1)-N(2)#1 135.0(2) C(6)-C(7)-C(8) 121.2(8)
N(1)#1-Ca(1)-N(2)#1 62.8(2) C(9)-C(8)-C(12) 116.4(8)
O(6)-Ca(1)-O(3) 123.2(2) C(9)-C(8)-C(7) 123.3(8)
O(5)-Ca(1)-O(3) 74.1(2) C(12)-C(8)-C(7) 120.2(8)
O(3)#1-Ca(1)-O(3) 99.25(10) C(8)-C(9)-C(10) 119.6(9)
O(1)#1-Ca(1)-O(3) 73.6(2) C(11)-C(10)-C(9) 118.6(9)
O(4)-Ca(1)-O(3) 50.9(2) N(2)-C(11)-C(10) 124.3(9)
N(1)#1-Ca(1)-O(3) 127.8(3) N(2)-C(11)-C(14) 113.0(9)
N(2)#1-Ca(1)-O(3) 148.8(2) C(10)-C(11)-C(14) 122.6(9)
O(6)-Ca(1)-C(14) 100.6(3) N(2)-C(12)-C(8) 125.1(8)
O(5)-Ca(1)-C(14) 93.5(3) N(2)-C(12)-C(13) 115.4(8)
O(3)#1-Ca(1)-C(14) 84.9(3) C(8)-C(12)-C(13) 119.5(8)
O(1)#1-Ca(1)-C(14) 86.2(3) N(1)-C(13)-C(5) 126.1(9)
O(4)-Ca(1)-C(14) 25.2(3) N(1)-C(13)-C(12) 116.3(8)
N(1)#1-Ca(1)-C(14) 148.7(3) C(5)-C(13)-C(12) 117.5(8)
N(2)#1-Ca(1)-C(14) 147.6(3) O(4)-C(14)-O(3) 125.6(10)
O(3)-Ca(1)-C(14) 25.9(3) O(4)-C(14)-C(11) 118.1(10)
C(1)-O(1)-Ca(1)#2 126.1(6) O(3)-C(14)-C(11) 116.3(10)
C(14)-O(3)-Ca(1)#2 125.3(6) O(4)-C(14)-Ca(1) 60.6(5)
C(14)-O(3)-Ca(1) 88.3(7) O(3)-C(14)-Ca(1) 65.8(5)
Ca(1)#2-O(3)-Ca(1) 146.2(3) C(11)-C(14)-Ca(1) 168.1(7)
Symmetry transformations used to generate equivalent atoms:
1:  -x, -y+½, z+½     2: -x, -y+½, z-½     3:  -x, -y+1, z  
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Table 7:  The anisotropic displacement parameters (Å2×103) for the [Ca(PDA)(H2O)2] complex.  
The anisotropic displacement factor exponent takes the form:  -2π2 [h2a*2U11 + ... + 
2hka*b*U12]. 
 
U11 U22 U33 U23 U13 U12
Ca(1) 33(1) 27(1) 39(1) -4(1) 5(1) -2(1)
O(1) 39(4) 47(5) 42(4) 2(3) -11(3) 2(3)
O(8A) 45(8) 49(10) 35(7) 13(8) 9(8) -9(6)
O(8B) 50(9) 38(10) 63(11) 17(9) 8(9) -1(7)
O(2) 54(4) 40(4) 38(4) -11(4) -10(4) 7(3)
O(3) 23(3) 22(3) 89(6) -11(4) 4(4) -2(3)
O(7) 66(10) 58(11) 41(7) -4(8) 22(7) -31(8)
O(5) 44(4) 50(5) 82(6) -26(5) 22(4) -16(4)
O(6) 37(3) 31(4) 40(4) 1(3) -3(3) 3(3)
O(4) 41(4) 22(4) 50(4) -10(3) 22(3) 1(3)
N(1) 44(4) 13(4) 36(4) -3(3) -5(4) -2(3)
N(2) 32(4) 13(4) 27(4) 7(3) 9(3) 1(3)
C(1) 47(6) 9(5) 45(6) 6(4) -11(5) -2(4)
C(2) 43(5) 23(5) 23(4) 9(4) -12(4) -4(4)
C(3) 38(5) 42(7) 33(5) 1(5) -6(4) 8(4)
C(4) 41(5) 29(6) 34(5) 9(4) 1(4) 12(4)
C(5) 33(4) 18(4) 24(5) 3(4) 3(4) 5(4)
C(6) 30(5) 30(6) 49(6) 1(4) -2(4) -2(4)
C(7) 41(5) 17(5) 27(4) -3(4) -1(5) 3(4)
C(8) 36(5) 22(5) 25(4) -1(4) -6(4) -1(4)
C(9) 44(5) 22(5) 36(6) 10(4) -7(4) -1(4)
C(10) 25(4) 27(5) 35(4) 2(5) -4(5) -5(4)
C(11) 34(5) 29(5) 33(5) 16(4) 8(4) 0(4)
C(12) 40(5) 16(5) 37(5) 0(4) 6(4) 5(4)
C(13) 38(4) 23(4) 34(5) 8(4) -5(5) 1(4)
C(14) 34(5) 36(6) 55(7) 14(6) 3(5) -8(5)
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116.3°, respectively.  These bond angles were compared to the bond angles around theoretical, 
non-complexed PDA.  A Hyperchem MM+ geometry optimized calculation was performed for 
the non-complexed PDA ligand.  These corresponding bond angles, determined from 
Hyperchem, were 119.1° and 116.3° and compared to the experimental bond angles of N(2)-
C(11)-C(14) and O(3)-C(14)-C(11) for the [Ca(PDA)(H2O)2] complex.  This comparison showed 
a minimal deviation from the theoretical bond angles of the non-complexed PDA when 
compared to the    [Ca(PDA)(H2O)2] complex.  Therefore, the strain energy is minimized for 
PDA when complexed with Ca(II).   
 
     DMOPA crystal structure 
 Crystals of 2,9-bis(carbomethoxy)-1,10-phenanthroline monohydrate, DMOPA, were 
determined to be an impurity of PDA after recrystallization from methanol.  The IR analysis of 
DMOPA is shown in Figure 49 and has a C=O stretch at 1724 cm-1, which is much lower than 
that for PDA.  These crystals were found as white platelets that bared no resemblance to the 
yellow, needle-like crystals of PDA.  The planar crystal structure of DMOPA is illustrated in 
Figure 50, which shows a molecule of H2O placed equidistant from the two oxygen atoms of the 
carbomethoxy groups.  This crystal structure shows the affect that preorganization has, since 
DMOPA has the ability to integrate a H2O molecule into its structure.  The more flexible analog 
of DMOPA, N,N´-bis(carbomethoxy)-ethylenediamine, does not have the structural rigidity 
needed to incorporate a water molecule into its crystal structure. 
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Figure 49:  The IR spectrum of 2,9-bis(carbomethoxy)-1,10-phenanthroline. 
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Figure 50:  The crystal structure and atom assignments for 2,9-bis(carbomethoxy)-1,10-
phenanthroline monohydrate (DMOPA·H2O). 
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153Gd(III) Radiolabeling of PDA 
 Three separate 153Gd(III) radiolabeling experiments were performed for PDA to 
determine the stability of the 153Gd(III)-PDA complex and its possible biomedical application as 
a contrast agent for MRI.  The first of the 153Gd(III) radiolabeling experiments confirmed what 
was found for the titration experiments for PDA with Gd(III).  A radio-TLC experiment was 
performed and verified that PDA formed a complex with 153Gd(III).  The conditions for the 
radio-TLC yielded Rf values of 0.3 for the 153Gd(III)-PDA complex and 0.0 for 153Gd(III) with 
ethanol as the mobile phase.  The radio-TLC diagram of 153Gd(III)-PDA and 153Gd(III) is shown 
in Figure 51. 
 The second experiment showed that the 153Gd(III)-PDA displayed a remarkable stability 
when exposed to a competing ligand, DTPA, in equimolar amounts.  This was unexpected, since 
DTPA is an unpreorganized octadentate ligand that would normally overcome a tetradentate 
ligand, such as PDA.  The affect of preorganization can be seen by this competition experiment.  
A radio-TLC experiment was conducted to determine how much of the 153Gd(III) was in PDA 
versus DTPA.  The conditions for the radio-TLC experiment yielded Rf values of 0.0 for 153Gd-
PDA and 0.6 for 153Gd-DTPA with 1:1 methanol/10% ammonium acetate.  The radio-TLC 
diagram, illustrated in Figure 52, showed that 50% of the 153Gd(III) was complexed with PDA 
and 50% of the 153Gd(III) was complexed with DTPA.  Therefore, the ability for PDA to 
complex 153Gd(III) competitively with DTPA was verified by radio-TLC analysis.   
 The third experiment was performed to determine the stability of the 153Gd(III)-PDA 
complex in a biological medium, rat serum.  Radio-TLC analysis was performed after 5 minutes 
of incubating a solution of 153Gd(III)-PDA complex in rat serum.  The results gave two possible 
scenarios for the fate of the 153Gd(III)-PDA complex.  The 153Gd(III)-PDA peak had disappeared  
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Figure 51:  The radio-TLC diagram of the 153Gd(III)-PDA complex. 
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Figure 52:  The radio-TLC diagram for the competition experiment of PDA and DTPA for 
153Gd(III). 
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and a new peak was shown in Figure 53.  This suggested that either the 153Gd(III) was displaced 
from the 153Gd(III)-PDA complex into the proteins of the rat serum or the 153Gd(III)-PDA 
complex was bound to the proteins. 
 
CONCLUSIONS 
For years, macrocycles have been used to enhance the thermodynamic stability, as well 
as the metal ion selectivity, of a metal-ligand complex.  The ability to selectively chelate a metal 
ion is of particular importance to inorganic chemistry.  This is typically done using ligand donor 
atoms with higher affinities for the desired metal ion to be chelated, matching the number of 
ligand donor atoms closely with coordination number for the metal ion, or by introducing a size-
selective framework for the donor atoms of the ligand.  1,10-phenanthroline-2,9-dicarboxylate 
(PDA) exhibits selectivity for larger metal ions using these principles of ligand design.     
Characterization of PDA by IR and 1H-NMR spectroscopy showed that pure PDA was 
synthesized by following synthetic techniques from Chandler, et. al., although some 
inconsistencies were shown.  Methanol may not be the most suitable recrystallization solvent 
since 2,9-bis(carbomethoxy)-1,10-phenanthroline (DMOPA) was determined to be a byproduct 
from the recrystallization.   
UV/Vis absorption spectrophotometry proved to be an effective and valuable technique 
for the detection of metal-PDA complexes in aqueous solutions as a function of pH.  Absorption 
bands for PDA in the UV region facilitated the detection metallation and demetallation of PDA.   
Formation constants, log K1 values, for larger metal ions (approximately 1.00Å) were shown to 
be substantially higher for the preorganized structure of PDA, compared to the unpreorganized  
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Figure 53:  The radio-TLC diagrams of the 153Gd(III)-PDA complex before and after rat serum 
was added to the sample. 
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analog of PDA, EDDA.  A decrease in formation constants for smaller metal ions was also seen, 
relative to EDDA.  PDA effectively competed with EDTA and even DTPA for metal ions at 
lower pH values, which allowed for the determination of formation constants for PDA with 
metal ions.  This is remarkable, since PDA is only a tetradentate ligand, having two negative 
oxygen and two neutral nitrogen donor atoms.  Overall, the hemicyclic effect, or the effect of 
having terminal donor atoms on a preorganized ligand, has yielded an enormous improvement 
for metal-PDA complex stability.   
From the 153Gd(III) radiolabeling experiment, PDA was shown to be an effective ligand 
for chelating the Gd(III) metal ion.  The competition experiment between PDA and DTPA for 
153Gd(III) showed equimolar concentrations of Gd(III)-PDA and Gd(III)-DTPA complexes in 
solution, which suggested that PDA has an enormous affinity for Gd(III).  Although PDA has 
proven its ability to complex Gd(III), alterations may need to be made to the structure of PDA, 
such as adding sulfonic acid substituents to the hydrophobic backbone of PDA to increase water 
solubility, in order to be placed into a biological medium.  Future, water-soluble derivatives of 
PDA may prove to be valuable MRI contrasting agents.  Judging from the formation constants, 
the preorganized structure of PDA selectively chelates larger metal ions, normally used in 
contrasting agents, over smaller metal ions, such as Zn(II), found in the body.  In particular, the 
size selectivity of PDA was illustrated in the crystal structure of [Ca(PDA)(H2O)2], where the 
Ca(II) metal ion showed a proper fit between the carboxylate groups of PDA with minimal strain 
on the overall complex.   
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